The Medicube Story
Medicube went from cheap pore pads to a billion-dollar K-beauty tech brand in under a decade. Here is the independent, sourced version of how, who owns it, and why it matters when you are deciding what to buy.
Written by the Medicube Picks editorial team. We are independent and not affiliated with Medicube or APR Corp. Figures are drawn from public reporting (company filings, Forbes, Korea Times, Business of Fashion and similar), not from Medicube's own marketing.
Who owns Medicube?
Medicube is a brand of APR Corp, a South Korean beauty-and-technology company founded in 2014 by Byunghoon (Victor) Kim, which started with the brand Aprilskin. Medicube itself launched in July 2016, positioned around a simple idea: bring the kind of results you would associate with a dermatology clinic into an affordable at-home routine.
From pore pads to a public company
Medicube's early traction came from inexpensive, high-repeat products, most famously the Zero Pore pads, which built a large, loyal customer base. APR then layered a much higher-margin product line on top: the Age-R at-home beauty devices. That "cheap consumables to build the audience, premium devices to build the margin" model is central to understanding the brand, and it is why the range spans both twelve-dollar pads and two-hundred-dollar gadgets.
In February 2024, APR Corp listed on the Korea Exchange. The IPO raised roughly US $71 million, the stock jumped on debut, and the company was valued at around US $1.8 billion, a striking number for a brand still best known to many shoppers for viral toner pads.
How big is it now?
APR has grown fast. Public reporting puts its 2025 revenue at roughly KRW 1.5 trillion (about US $1.1 billion), with the clear majority earned overseas rather than in Korea, and the Age-R devices making up a large share of the total. In the US, Medicube has been reported among the top-selling skincare brands on Amazon, and it has leaned heavily on TikTok Shop, where its lifetime sales run into the hundreds of millions of dollars across more than a million units.
Why this matters when you are buying
Two takeaways for shoppers. First, the brand's scale and public-company status mean the products are real, widely used and consistently stocked, not a fly-by-night dupe operation. Second, the business model explains the pricing: the cheap pads and serums are genuinely good value and act as an entry point, while the devices carry the premium. That is not a criticism, just useful context. Our job is to tell you honestly which Medicube products are worth it and which are not, whatever the marketing says. Start with our product finder or the best-of guides.
Frequently asked questions
Who owns Medicube?
Medicube is owned by APR Corp (also written APR Co., Ltd.), a South Korean beauty and technology company founded in 2014. APR is publicly listed on the Korea Exchange, where it floated in February 2024.
When was Medicube founded?
The Medicube brand launched in July 2016 under APR Corp, with the stated aim of bringing dermatology-clinic style results into an at-home routine.
Is Medicube a big company?
Yes. Its parent APR Corp reported roughly KRW 1.5 trillion (about US $1.1 billion) in 2025 revenue, with the large majority coming from outside Korea. Its Age-R devices make up a large share of that revenue.